Boosted- lopinavir versus boosted- atazanavir plus two nucleoside reverse transcriptase inhibitors in second- line antiretroviral therapy in HIV-1 infected patients in Abidjan, Ivory Coast
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2016, Vol 6, Issue 4
Abstract
Introduction: Atazanavir is a protease inhibitor recently introduce in the therapeutic arsenal for second-line antiretroviral therapy in Ivory Coast. The objective of this study was to compare the efficacy and safety of a second-line treatment with 2 NRTIs + boosted lopinavir (LPV/r) versus 2 NRTIs + boosted atazanavir (ATV/r) in HIV-1 positive patients in Abidjan. Patients and Methods: Retrospective, comparative, single-center study, in 194 HIV-1 positive patients (143 with LPV/r, 51 with ATV/r), failed a first-line treatment, followed in Abidjan on 1 May 2009 to 30 June 2010. The analysis focused on clinical parameters and immuno-virological data. The principal judgement criterion was the proportion of patients with undetectable viral load in both groups after 12 months of HAART. Tolerance was found on the frequency of adverse events grade 3-4 during follow-up. Results: Clinically, improvement of the general condition and regression of opportunistic infections was similar in both groups. The average gain of CD4 after 12 months of follow-up was +357/mm3 in the LPV/r group versus +278 mm3 for ATV/r group (p = 0.012). The percentage of patients with undetectable viral load was similar in both groups (92% vs. 96% ; p = 0.535). The frequency of grade 3-4 adverse events was similar in both groups. Conclusion: HAART with LPV/r is at least as efficient as with ATV/r in second-line treatment, in terms of viral load reduction, with better recovery of CD4. LPV/r is an excellent second-line treatment in resource-limited countries. J Microbiol Infect Dis 2016;6(4): 149-155
Authors and Affiliations
Eboi Ehui, Alain N’douba Kassi, Gisèle Affoué Kouakou, Adama Doumbia, Chrysostome Melaine Mossou, Sinaly Kamagaté, Aristophane Koffi Tanon, Fréderic Nogbou Ello, Serge Eholié
Keywords
Related Articles
- EP ID EP412712
- DOI 10.5799/jmid.328859
- Views 83
- Downloads 0
Laktozu fermente eden Salmonella paratyphi A: Bir vaka sunumu
Salmonella genusunda 2500’den fazla antijenik tipleri bulunmaktadır. Salmonella typhi ve Salmonella paratyphi A, B ve C tifo etkenidirler. Karakteristik olarak bu dört tür de laktozu fermente etmezler. Burada, 12 günlük...
Comparison of fluconazole and posaconazole for fungal prophylaxis in high- risk patients with hematological malignity
Objective:To compare the frequency of fungal infection and mortality rates in patients with hematological malignity and receiving either flucanazole (FLU) or posaconazole (POS) prophylaxis. Methods:This retrospective,...
Mide kanserinde Helicobacter pylori ile DNA hipermetilasyonunun ilişkisi
Mide kanseri (MK) tüm dünyada sık görülen kanserlerden biridir. MK oluşumu genetik ve epigenetik değişikliklerin birikimi ile çok adımlı ilerleme gösterir. Deoksiribonükleik asit (DNA) dizisi değişmeden gen ifadesinde me...
A nosocomial outbreak of Crimean-Congo hemorrhagic fever
Objectives: An outbreak of nosocomial Crimean-Congo Hemorrhagic Fever (CCHF) occurred in a university hospital in May 2014. The index case was hospitalized with a preliminary diagnosis of intoxication, liver failure and...
Telaprevir-related DRESS syndrome complicating hepatitis C treatment
In chronic hepatitis C patients telaprevir attracts attention with high sustained virologic response and short term treatment however it is associated a new spectrum of adverse events, especially several cutaneous manif...